Sabra Health Care REIT Reports Officer/Director Changes & Compensation

Ticker: SBRA · Form: 8-K · Filed: 2025-03-24T00:00:00.000Z

Sentiment: neutral

Topics: management-change, compensation, governance

Related Tickers: SBRA

TL;DR

Sabra REIT (SBRA) filed an 8-K detailing director/officer changes and compensation updates.

AI Summary

Sabra Health Care REIT, Inc. filed an 8-K on March 24, 2025, reporting events as of March 20, 2025. The filing covers the departure of directors or certain officers, the election of directors, the appointment of certain officers, and compensatory arrangements for certain officers. It also includes a Regulation FD Disclosure and Financial Statements and Exhibits.

Why It Matters

Changes in key leadership and compensation structures can signal shifts in company strategy or governance, impacting investor confidence and future performance.

Risk Assessment

Risk Level: medium — Changes in executive and director positions, along with compensation details, can introduce uncertainty regarding future strategy and operational direction.

Key Players & Entities

FAQ

What specific officer or director positions were affected by the changes reported in this 8-K?

The filing indicates changes related to 'Departure of Directors or Certain Officers' and 'Appointment of Certain Officers', but the specific names and positions are not detailed in the provided text.

What is the effective date of the events reported in this 8-K?

The date of the earliest event reported is March 20, 2025.

What are the main categories of information disclosed in this 8-K filing?

The filing covers departure/election/appointment of directors and officers, compensatory arrangements, Regulation FD Disclosure, and Financial Statements and Exhibits.

What is the company's state of incorporation and principal executive office location?

The company is incorporated in Maryland and its principal executive offices are located at 1781 Flight Way, Tustin, CA 92782.

What is the SEC file number for Sabra Health Care REIT, Inc.?

The SEC file number for Sabra Health Care REIT, Inc. is 001-34950.

From the Filing

0001492298-25-000011.txt : 20250324 0001492298-25-000011.hdr.sgml : 20250324 20250324092059 ACCESSION NUMBER: 0001492298-25-000011 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 15 CONFORMED PERIOD OF REPORT: 20250320 ITEM INFORMATION: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers ITEM INFORMATION: Regulation FD Disclosure ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20250324 DATE AS OF CHANGE: 20250324 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Sabra Health Care REIT, Inc. CENTRAL INDEX KEY: 0001492298 STANDARD INDUSTRIAL CLASSIFICATION: REAL ESTATE INVESTMENT TRUSTS [6798] ORGANIZATION NAME: 05 Real Estate & Construction EIN: 272560479 STATE OF INCORPORATION: MD FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-34950 FILM NUMBER: 25762558 BUSINESS ADDRESS: STREET 1: 1781 FLIGHT WAY CITY: TUSTIN STATE: CA ZIP: 92782 BUSINESS PHONE: 888-393-8248 MAIL ADDRESS: STREET 1: 1781 FLIGHT WAY CITY: TUSTIN STATE: CA ZIP: 92782 8-K 1 sbra-20250320.htm 8-K sbra-20250320 false 0001492298 0001492298 2025-03-20 2025-03-20     UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported):  March 20, 2025 SABRA HEALTH CARE REIT, INC. (Exact name of registrant as specified in its charter)   Maryland   001-34950   27-2560479 (State of Incorporation)   (Commission File Number)   (I.R.S. Employer Identification No.)   1781 Flight Way Tustin CA 92782 (Address of principal executive offices) (Zip Code) Registrant's telephone number including area code: ( 888 )  393-8248   (Former name or former address, if changed since last report.) Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:   ☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) ☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) ☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act: Title of each class Trading symbol(s) Name of each exchange on which registered Common stock, $0.01 par value SBRA The Nasdaq Stock Market LLC Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter). Emerging growth company ☐ If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐ Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. (b)    On March 24, 2025, Sabra Health Care REIT, Inc. (“Sabra” or the “Company”) announced that Talya Nevo-Hacohen, the Company’s Executive Vice President, Chief Investment Officer and Treasurer, has decided to retire from Sabra, effective December 31, 2025, and Darrin Smith, Sabra’s Executive Vice President – Investments, is expected to assume this position effective January 1, 2026. The Company expects that Ms. Nevo-Hacohen will remain in a consulting role with Sabra following her retirement pursuant to the consu

View on Read The Filing